NFKB1 and glucose metabolism disease: Hyperglycemia and glucose metabolism disorders can lead to the increased production of advanced glycation end products, which can activate the oxygen free radicals and NF-κB signaling pathways after binding to receptors, leading to the oxidative stress and inflammation [30].